Total | ECMO survival | Hospital survival | 12 month survival | Median 5-year costs (€) | Total costs (€) | Cost per life saved (€) | |
---|---|---|---|---|---|---|---|
Costs and survival of 80 children treated with ECMO in the period 1997–2002. The patient age at initiation of ECMO was classified as neonatal (0–28 days), infant (28 days–18 months), or paediatric (>18 months), and the indication for ECMO was classified as respiratory, congenital heart disease, or acquired heart disease (myocarditis or cardiomyopathy). Children who received a cardiac transplant while receiving ECMO are represented in the cardiac transplant rescue category. Values are number (%). | |||||||
*One congenital diaphragmatic hernia, three meconium aspiration, three persistent pulmonary hypertension, two alveolar capillary dysplasia. | |||||||
†Wegener’s syndrome, pneumonitis, lung transplant, Bordetella pertussis. | |||||||
¶p = 0·002 compared with children not receiving cardiac transplantation (Wilcoxon rank sum test). | |||||||
All | 80 | 47 (59) | 31 (39) | 29 (36) | 40 935 | 5 117 551 | 176 467 |
Congenital heart disease | 55 | 33 (60) | 19 (35) | 16 (29) | 43 943 | 3 819 204 | 238 700 |
Myocarditis/cardiomyopathy | 7 | 5 (71) | 5 (71) | 5 (71) | 68 877 | 559 582 | 111 916 |
Neonatal respiratory* | 9 | 4 (44) | 3 (33) | 3 (33) | 28 632 | 276 977 | 92 326 |
Paediatric or infant respiratory† | 4 | 3 (75) | 3 (75) | 3 (75) | 65 894 | 371 695 | 121 665 |
Neonates | 32 | 20 (63) | 13 (41) | 12 (38) | 41 620 | 2 410 026 | 200 835 |
Infants | 27 | 15 (56) | 7 (26) | 4 (15) | 34 386 | 1 188 019 | 297 004 |
Paediatric | 21 | 12 (57) | 11 (52) | 10 (48) | 48 580 | 1 519 507 | 151 951 |
Cardiac transplant rescue | 8 | 7 (88) | 7 (88) | 6 (75) | 149 212¶ | 1 193 089 | 198 848 |